Cancer survivors most frequently seek information about recurrence
the ONA take:
According to a new study published online first in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from the University of Pennsylavnia's Annenberg School of Communication have found that cancer survivors most frequently seek information about cancer recurrence, but information needs vary depending on cancer type.
For the study, researchers surveyed over 2,000 cancer survivors three times over a 3-year period. Participants were survivors of breast, colon, and prostate cancer. Results showed that across all participants, decreasing the risk for cancer recurrence was the most frequently researched topic.
In addition, survivors of breast cancer were more likely to seek information about late effects and their family members' risks than colon and prostate cancer survivors and were less likely to seek information about their risks of cancer recurrence in later years than during the year following diagnosis.
Researchers found that female colon cancer survivors were more likely to seek information about certain topics in later years than female breast cancer survivors, which may be due to more information about breast cancer and survivorship resources for breast cancer survivors being readily available.
The findings demonstrate various points that health care providers can educate their patients on cancer recurrence and survivorship.
Cancer survivors most frequently seek information about cancer recurrence.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|